Literature DB >> 15605664

Insulin resistance in chronic hepatitis C.

G Yazicioglu1, F Isitan, H Altunbas, I Suleymanlar, M Ozdogan, M K Balci, U Karayalcin.   

Abstract

Insulin resistance (IR), glucose intolerance and diabetes mellitus are commonly associated with cirrhosis. The exact pathogenetic mechanisms responsible are still unknown; however, they may be related to both hepatitis C virus itself and to liver injury. IR may be the earliest abnormality, which in the following years may progress to clinical diabetes mellitus. The aim of this study was to investigate the presence of IR by euglycaemic hyperinsulinemic clamp technique, in chronic hepatitis C patients. 15 patients and nine healthy controls without any known condition that may affect IR were enrolled to the study. Chronic hepatitis C was diagnosed by liver biopsy (hepatic activity index was also determined in 10 patients) and appropriate viral and biochemical tests. Eight patients were given interferon therapy, which had been stopped for at least 3 months before the study. Euglycaemic hyperinsulinemic clamp technique was performed as previously described and peripheral glucose utilisation rate, M value, was calculated in mg/kg/min by infusion of 40 IU/m2/min regular insulin. M value of the control group was significantly higher than that of chronic hepatitis C patients (M = 5.1+/-1 vs. 3.7+/-1; p = 0.004), which was consistent with IR in the patient group. There was no significant correlation between the M value and alanine aminotransferase, aspartate aminotransferase and hepatic activity index (p = 0.621, 0.549, 0.479, respectively). Our results suggest that IR is present in chronic hepatitis C patients; it is not directly related to hepatic injury, moreover, it may be associated with some component(s) inherent to hepatitis C virus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15605664     DOI: 10.1111/j.1742-1241.2004.00170.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  7 in total

1.  Severe insulin resistance in a treatment-naive chronic hepatitis C patient.

Authors:  Omar Khokhar; Jacqueline Fischer
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-08

2.  Effect of Breathwalk on body composition, metabolic and mood state in chronic hepatitis C patients with insulin resistance syndrome.

Authors:  M Vázquez-Vandyck; S Roman; J L Vázquez; L Huacuja; G Khalsa; R Troyo-Sanromán; A Panduro
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

3.  Prevalence of Hepatitis C among Multi-transfused Thalassaemic Patients in Oman: Single centre experience.

Authors:  Khalid Al-Naamani; Ibrahim Al-Zakwani; Siham Al-Sinani; Fauzia Wasim; Shahina Daar
Journal:  Sultan Qaboos Univ Med J       Date:  2015-01-21

4.  Mechanisms of glucose intolerance in patients with chronic hepatitis C: implications for treatment.

Authors:  Pierre M Gholam; Angela F Domingo
Journal:  Curr Infect Dis Rep       Date:  2007-03       Impact factor: 3.725

5.  HIV infection and the risk of diabetes mellitus.

Authors:  Adeel A Butt; Kathleen McGinnis; Maria C Rodriguez-Barradas; Stephen Crystal; Michael Simberkoff; Matthew Bidwell Goetz; David Leaf; Amy C Justice
Journal:  AIDS       Date:  2009-06-19       Impact factor: 4.177

6.  Insulin sensitivity and variability in hepatitis C virus infection using direct measurement.

Authors:  Nizar A Mukhtar; Peter Bacchetti; Claudia E Ayala; Jennifer Melgar; Spencer Christensen; Jacquelyn J Maher; Mandana Khalili
Journal:  Dig Dis Sci       Date:  2012-10-21       Impact factor: 3.199

Review 7.  Infectious Agents in Atherosclerotic Cardiovascular Diseases through Oxidative Stress.

Authors:  Marisa Di Pietro; Simone Filardo; Francesca Falasca; Ombretta Turriziani; Rosa Sessa
Journal:  Int J Mol Sci       Date:  2017-11-18       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.